September 2018 DAIDS Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Long-Acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children

For the published request for applications, see the November 20, 2018 Guide announcement, Long-Acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed).

Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional)

For the published request for applications, see the March 29, 2019 Guide announcement, Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional).

HIV/HBV Co-Infection: Research To Advance HBV Cure

For the published program announcement with set-aside funds, see the November 29, 2018 Guide announcement, Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed).

Novel RNAs in Virology (Including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery

For the published program announcement, see the April 3, 2019 Guide announcement, Novel RNAs in Virology (Including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21, Clinical Trial Not Allowed).

Content last reviewed on April 4, 2019